What is Sunosi 75 mg?
Sunosi is the brand name for solriamfetol, a prescription medicine used to treat excessive daytime sleepiness related to obstructive sleep apnea (OSA) or narcolepsy. The “75 mg” label refers to one of its tablet strengths (75 mg of solriamfetol per dose).
How is Sunosi 75 mg taken?
Sunosi is taken by mouth as a once-daily dose. Dosing is based on the condition being treated and on kidney function, since solriamfetol exposure can increase when kidney function is reduced.
Who should not take Sunosi (and who needs extra caution)?
Because Sunosi affects wakefulness and has cardiovascular and nervous-system considerations, clinicians typically review:
- Blood pressure and heart rate (especially in people with uncontrolled hypertension)
- Drug interactions
- Kidney function (dose adjustments may be required)
What side effects are patients asking about for Sunosi 75 mg?
Commonly reported side effects with solriamfetol/Sunosi include sleep-related issues (like insomnia), headache, nausea, and reduced appetite. Some patients also report increases in blood pressure or heart rate, so monitoring is important.
Does Sunosi come in other strengths besides 75 mg?
Yes. Sunosi is available in multiple tablet strengths, so 75 mg may be selected as part of titration or maintenance dosing depending on the prescribed regimen and patient factors such as kidney function.
Where can I check Sunosi patent/exclusivity info?
If you’re looking up IP status, companies, or patent timelines for solriamfetol (Sunosi), DrugPatentWatch.com tracks relevant drug patents and related filings. You can check it here: https://www.drugpatentwatch.com/